Canada · Health Canada Drug Product Database
BREO ELLIPTA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 89362
- DIN
- 02408872
- Form
- Powder
- Company as listed by source
- GLAXOSMITHKLINE INC
- Source status
- Marketed (2013-11-29)
- Source last updated
- 2026-06-16
Source-listed ingredients
- FLUTICASONE FUROATE — 100 MCG — per 1 ACT
- VILANTEROL (VILANTEROL TRIFENATATE) — 25 MCG — per 1 ACT
These values do not establish equivalence or a dose recommendation.
Packages
- 14/30 Doses
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →